For the quarter ending 2025-09-30, BICX has $7,533,473 in assets. $20,297,768 in debts.
| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Cash and cash equivalents | 287,688 | 111,872 | ||
| Accounts receivable, net | 194,442 | 51,242 | ||
| Grant receivable | 761,515 | 153,728 | ||
| Inventory | 155,367 | 133,597 | ||
| Prepaid expenses | 63,164 | 77,044 | ||
| Total current assets | 1,462,176 | 527,483 | ||
| Property and equipment, net | 7,685 | 11,083 | ||
| Right to use assets | 169,443 | 179,555 | ||
| Intangible assets, net | 3,011,833 | 3,080,422 | ||
| Goodwill | 2,840,400 | 2,840,400 | ||
| Deposits, long term | 41,936 | 41,936 | ||
| Total other assets | 5,894,169 | 5,962,758 | ||
| Total assets | 7,533,473 | 6,680,879 | ||
| Accounts payable and accrued expenses, including related party payables of 1,629,743 and 1,349,465, respectively | 12,400,939 | 11,805,777 | ||
| Deferred revenue-grant | 56,590 | 56,590 | ||
| Lease liability, short term | 41,686 | 41,686 | ||
| Notes payable, net of debt discount of 3,216 and 41,452 | 1,547,853 | 1,546,514 | ||
| Notes payable, related parties | 991,059 | 1,108,559 | ||
| Total current liabilities | 15,038,127 | 14,559,126 | ||
| Eidl loan, long term | 69,803 | - | ||
| Upfront purchase price liability | 85,440 | 241,662 | ||
| Economic injury disaster loan, long term | - | 70,290 | ||
| Royalty liability | 317,577 | 147,871 | ||
| Royalty obligation, net of discount of 4,184,810 and 4,418,698, related parties | 4,659,064 | 4,537,290 | ||
| Lease liability, long term | 127,757 | 137,869 | ||
| Total liabilities | 20,297,768 | 19,694,108 | ||
| Preferred stock, no par value 600,000 shares authorized at september 30, 2025 and december 31, 2024 | 0 | - | ||
| Preferred stock, no par value 600,000 shares authorized at september 30, 2025 and december 31, 2024-Series AConvertible Preferred Stock | 16,000 | 16,000 | ||
| Preferred stock, no par value 600,000 shares authorized at september 30, 2025 and december 31, 2024-Series BConvertible Preferred Stock | 5,616 | 5,616 | ||
| Common stock, 0.001 par value 750,000,000 shares authorized, 20,188,029 and 13,299,349 shares issued and outstanding as of as of september 30, 2025 and december 31, 2024, respectively | 20,188 | 17,282 | ||
| Common stock subscribed | 100,000 | 100,000 | ||
| Additional paid in capital | 73,575,400 | 72,520,867 | ||
| Accumulated deficit | -87,201,843 | -85,283,967 | ||
| Total deficit attributable to biocorrx, inc | -13,484,639 | -12,624,202 | ||
| Non-controlling interest | 720,344 | -389,027 | ||
| Total deficit | -12,764,295 | -13,013,229 | ||
| Total liabilities and deficit | 7,533,473 | 6,680,879 | ||
BioCorRx Inc. (BICX)
BioCorRx Inc. (BICX)